Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 16:10:2042098619843365.
doi: 10.1177/2042098619843365. eCollection 2019.

Influence of pharmacist intervention on drug safety of geriatric inpatients: a prospective, controlled trial

Affiliations

Influence of pharmacist intervention on drug safety of geriatric inpatients: a prospective, controlled trial

Angela Nachtigall et al. Ther Adv Drug Saf. .

Abstract

Background: Demographic shift leads to an increasing number of geriatric patients suffering from multimorbidity and resulting polypharmacy. Polypharmacy is shown to be associated with drug-related problems (DRPs) and increased morbidity. For Germany, a hospital-based intervention may be successful optimizing of polypharmacy. The aim of this study was to reduce DRPs in geriatric inpatients by a structured pharmacist's intervention and to measure the acceptance rate of pharmaceutical recommendations.

Methods: This study followed an open, prospective, quasi-randomized, controlled design and was conducted in a geriatric department in a teaching hospital in Germany. Patients of all sexes were included, with a minimum age of 70 years, a written informed consent and a regular intake of at least five drugs daily. Primary outcome was the percentage of patients having a DRP at admission and discharge. A DRP was defined as a prescription without indication or a relevant drug-drug interaction or prescription of a potentially inappropriate medication or presence of an adverse drug reaction. Recommendations were classified and discussed face to face. Statistical analyses were performed using a full-set analysis and a matched-pairs design.

Results: Within 12 months, 411 patients were recruited with median age of 82 years (intervention: n = 209; control: n = 202). Median number of drugs at admission was 10 (range 5-24), at discharge 9 (range 3-21). In the intervention group, the percentage of patients with a DRP was reduced from 86.6% to 56.0%; in the control group, from 76.7% to 76.2% (p value < 0.001). Medication appropriateness index score was reduced by 56% in the intervention group and by 0.2% in the control group (p value < 0.001). Implementation rate of the pharmaceutical recommendation was 80%.

Conclusion: This prospective controlled trial showed that a pharmacist's intervention was successful in optimizing polypharmacy in geriatric inpatients.

Keywords: drug safety; geriatric inpatients; medication appropriateness index; pharmaceutical intervention; polypharmacy; potentially inappropriate medication.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Study design and patient enrolment.
Figure 2.
Figure 2.
Pharmacy problem categories according to Hoth et al. detected by the pharmacist and discussed with the physician. ADE, adverse drug event; ADR, adverse drug reaction; PRISCUS, .
Figure 3.
Figure 3.
Type of pharmaceutical recommendation according to Hoth et al. and rate of acceptance.

Similar articles

Cited by

References

    1. Lehnert T, Heider D, Leicht H, et al. Review: Health care utilization and costs of elderly persons with multiple chronic conditions. Med Care Res Rev 2011; 68: 387–420. - PubMed
    1. Van den Akker M, Buntinx F, Knottnerus JA. Comorbidity or multimorbidity. Eur J Gen Pract 2009; 2: 65–70.
    1. Reeve E, Wiese MD, Mangoni AA. Alterations in drug disposition in older adults. Expert Opin Drug Metab Toxicol 2015; 11: 491–508. - PubMed
    1. Gnjidic D, Johnell K. Clinical implications from drug-drug and drug-disease interactions in older people. Clin Exp Pharmacol Physiol 2013; 40: 320–325. - PubMed
    1. Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol 2012; 65: 989–995. - PubMed

LinkOut - more resources